Drug Profile
Progestogen receptor agonist - Bayer
Alternative Names: Progestin receptor agonist - BayerLatest Information Update: 06 Oct 2006
Price :
$50
*
At a glance
- Originator Bayer
- Class
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 06 Oct 2006 Discontinued - Phase-I for Postmenopausal osteoporosis in Germany (unspecified route)
- 14 Feb 2001 Phase-I clinical trials for Postmenopausal osteoporosis in Germany (Unknown route)